Connect with us

Technology

Sanofi commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to increase diversity in clinical studies

Published

on

BRIDGEWATER, N.J., Oct. 16, 2024 /PRNewswire/ — Sanofi announced today it will contribute $18 million to three Historically Black Medical Schools to help the institutions work to increase diversity in clinical studies. The investment over 10 years is aimed at strengthening Centers of Excellence in clinical study diversity at Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine.

Funding will be used to hire clinical research staff, establish infrastructure such as online chat services and pharmacy upgrades, create customized training programs, and more. Each of the Centers of Excellence have their own specific needs, which will help them harness their insights into the underrepresented communities they serve as they seek to increase representation and improve diversity in clinical studies.

Lionel Bascles
SVP, Global Head of Clinical Trials and Operations, Sanofi
“At Sanofi, our mission is to chase the miracles of science to improve people’s lives, and this means all people’s lives, regardless of their race or ethnicity. By partnering with these three esteemed Historically Black College and University medical schools, we hope to facilitate new inroads to communities that have been underrepresented in healthcare for far too long. Increasing diversity and inclusion is essential to the research and development of medicines and vaccines for people of all backgrounds.”

Valerie Montgomery Rice, MD, FACOG
President and CEO, Morehouse School of Medicine
Morehouse School of Medicine is exceptionally grateful to Sanofi for this investment in our clinical study diversity Center of Excellence. We look forward to a robust partnership as we work to increase diversity in clinical studies and develop advanced opportunities for researchers, leading to greater health equity. More diversity in clinical studies will ensure traditionally underserved populations receive the very latest cutting-edge therapeutic innovations.”

Sanofi is a global innovator in the Diversity, Equity and Inclusion space, including by pioneering the international effort A Million Conversations to examine trust gaps in the healthcare system. In the U.S., Sanofi and the National Association for the Advancement of Colored People (NAACP) announced a strategic partnership in July that is aimed at advancing health equity for Black and underserved communities.

About Sanofi
We are an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Our team, across the world, is dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.

Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY

Media Relations
Sandrine Guendoul | + 33 6 25 09 14 25 | sandrine.guendoul@sanofi.com
Evan Berland | +1 215 432 0234 | evan.berland@sanofi.com
Timothy Gilbert | + 1 516 521 2929 | timothy.gilbert@sanofi.com

Investor Relations
Thomas Kudsk Larsen |+ 44 7545 513 693 | thomas.larsen@sanofi.com
Alizé Kaisserian | + 33 6 47 04 12 11 | alize.kaisserian@sanofi.com
Arnaud Delépine | + 33 6 73 69 36 93 | arnaud.delepine@sanofi.com
Corentine Driancourt | + 33 6 40 56 92 21 | corentine.driancourt@sanofi.com
Felix Lauscher | + 1 908 612 7239 | felix.lauscher@sanofi.com
Tarik Elgoutni| + 1 617 710 3587 | tarik.elgoutni@sanofi.com
Nathalie Pham | + 33 7 85 93 30 17 | nathalie.pham@sanofi.com

Sanofi Forward-Looking Statements
This press release contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts. These statements include projections and estimates and their underlying assumptions, statements regarding plans, objectives, intentions, and expectations with respect to future financial results, events, operations, services, product development and potential, and statements regarding future performance. Forward-looking statements are generally identified by the words “expects”, “anticipates”, “believes”, “intends”, “estimates”, “plans” and similar expressions. Although Sanofi’s management believes that the expectations reflected in such forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Sanofi, that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include among other things, the uncertainties inherent in research and development, future clinical data and analysis, including post marketing, decisions by regulatory authorities, such as the FDA or the EMA, regarding whether and when to approve any drug, device or biological application that may be filed for any such product candidates as well as their decisions regarding labelling and other matters that could affect the availability or commercial potential of such product candidates, the fact that product candidates if approved may not be commercially successful, the future approval and commercial success of therapeutic alternatives, Sanofi’s ability to benefit from external growth opportunities, to complete related transactions and/or obtain regulatory clearances, risks associated with intellectual property and any related pending or future litigation and the ultimate outcome of such litigation, trends in exchange rates and prevailing interest rates, volatile economic and market conditions, cost containment initiatives and subsequent changes thereto, and the impact that pandemics or other global crises may have on us, our customers, suppliers, vendors, and other business partners, and the financial condition of any one of them, as well as on our employees and on the global economy as a whole. The risks and uncertainties also include the uncertainties discussed or identified in the public filings with the SEC and the AMF made by Sanofi, including those listed under “Risk Factors” and “Cautionary Statement Regarding Forward-Looking Statements” in Sanofi’s annual report on Form 20-F for the year ended December 31, 2023. Other than as required by applicable law, Sanofi does not undertake any obligation to update or revise any forward-looking information or statements.

All trademarks mentioned in this press release are the property of the Sanofi group.

View original content:https://www.prnewswire.com/news-releases/sanofi-commits-18-million-to-howard-university-college-of-medicine-meharry-medical-college-and-morehouse-school-of-medicine-to-increase-diversity-in-clinical-studies-302276979.html

SOURCE Sanofi

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

OSL Achieves SOC 2 Type 2 Certification for Second Consecutive Year and Transitions to Annual Issuance

Published

on

By

The shift to annual issuance of the SOC 2 Type 2 report offers a more comprehensive view of control and operating effectiveness for data security.The report has examined OSL’s custody, automated trading services (ATS), and software-as-a-service (SaaS) operations.

HONG KONG, Jan. 16, 2025 /PRNewswire/ — OSL Digital Securities (OSL), a leading regulated digital asset platform and a member of OSL Group (863.HK), today announced the successful completion of its SOC 2 Type 2 report for the second consecutive year. The report includes the company’s custody, automated trading services (ATS), and software-as-a-service (SaaS) operations.

In line with industry best practices, OSL has extended the observation window of the SOC 2 Type 2 Report to 12 months. This change enables a more thorough and strategic evaluation of the controls and efficacy of its data security management, underscoring OSL’s strong dedication to transparency, compliance, and data protection. 

The SOC 2 Type 2 certification, conducted by a renowned Big Four accounting firm, highlights OSL’s high standards of security, availability, and confidentiality across its custody, ATS, and SaaS solutions. This certification provides important assurance to clients who require third-party validation to fulfill their due diligence and compliance requirements.

Kevin Cui, Executive Director and Chief Executive Officer of OSL, said: “Data security and protection are paramount in the digital asset industry. We have invested significantly into driving operational excellence and regulatory compliance, and maintaining our SOC 2 Type 2 certification is a key part of that commitment. Our ultimate goal is to continue leading and enhancing the security and compliance standards for our industry.”

SOC 2, which stands for “System and Organisation Controls 2”, is a framework that defines a set of rules and standards an organisation must follow to ensure the safety and security of the information it manages. It is an authoritative assurance report that is particularly vital for institutional clients, such as banks and audited firms.

About OSL

Backed by Asia’s leading public fintech and digital asset company, OSL Group (863.HK), formerly BC Technology Group, OSL is the world’s first SFC-licensed and insured digital asset platform. Founded in 2018, OSL has an established history in the sector and is recognised by many as the leader in providing comprehensive regulated and licensed digital asset solutions.

OSL offers Markets services (brokerage, exchange, and custody) and SaaS technology solutions, which deliver institutional clients in addition to professional and retail investors access to global liquidity through its best-in-class digital asset platform. OSL’s secured and insured hot and cold wallet infrastructure also ensures the safekeeping of digital assets with timely transaction settlements.

As the digital asset industry continues to evolve, so does OSL. OSL’s simple and tailored approach compliantly navigates international clients through the evolving digital assets environment.

For more information, visit: osl.com

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/osl-achieves-soc-2-type-2-certification-for-second-consecutive-year-and-transitions-to-annual-issuance-302352825.html

SOURCE OSL

Continue Reading

Technology

Transmission Electron Microscope Market to grow by USD 528.8 Million (2024-2028), driven by focus on nanotechnology, with a report on how AI is reshaping the landscape – Technavio

Published

on

By

NEW YORK, Jan. 16, 2025 /PRNewswire/ — Report with market evolution powered by AI – The global transmission electron microscope market  size is estimated to grow by USD 528.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 11.76%  during the forecast period. Increasing focus on nanotechnology is driving market growth, with a trend towards development of new forms of transmission electron microscopes. However, high cost and heavy excise duty of transmission electron microscopes  poses a challenge. Key market players include Advantest Corp., Agilent Technologies Inc., AMETEK Inc., Angstrom Advanced Inc., Bruker Corp., Carl Zeiss Stiftung, Danaher Corp., DELONG INSTRUMENTS AS, Hirox Co. Ltd., Hitachi Ltd., IXRF Inc., JEOL Ltd, NanoScience Instruments Inc., Nikon Corp., Nion, Olympus Corp., Oxford Instruments plc, Roper Technologies Inc., Thermo Fisher Scientific Inc., and VIDEOTON HOLDING ZRt.

AI-Powered Market Evolution Insights. Our comprehensive market report ready with the latest trends, growth opportunities, and strategic analysis- View Free Sample Report PDF

Forecast period

2024-2028

Base Year

2023

Historic Data

2017 – 2021

Segment Covered

Application (Life science, Material science, Nanotechnology, Semiconductor, and Others), End-user (Industries, Academic institutes, and Others), and Geography (APAC, North America, Europe, South America, and Middle East and Africa)

Region Covered

APAC, North America, Europe, South America, and Middle East and Africa

Key companies profiled

Advantest Corp., Agilent Technologies Inc., AMETEK Inc., Angstrom Advanced Inc., Bruker Corp., Carl Zeiss Stiftung, Danaher Corp., DELONG INSTRUMENTS AS, Hirox Co. Ltd., Hitachi Ltd., IXRF Inc., JEOL Ltd, NanoScience Instruments Inc., Nikon Corp., Nion, Olympus Corp., Oxford Instruments plc, Roper Technologies Inc., Thermo Fisher Scientific Inc., and VIDEOTON HOLDING ZRt

Key Market Trends Fueling Growth

The transmission electron microscope market is experiencing significant growth due to the development of new types of transmission electron microscopes. These advanced models include reflection electron microscopes (REMs), scanning-transmission electron microscopes (STEMs), low-voltage electron microscopes (LVEMs), and cryo-EM. Reflection electron microscopes (REMs) differ from traditional transmission electron microscopes by collecting electrons that are elastically scattered from the object, rather than those that pass through it. REMs are particularly useful when surface information of the specimen is required. Scanning-transmission electron microscopes (STEMs) are increasingly adopted in research laboratories due to their ability to produce images or results directly, without the need for interpretation. STEMs come in two types: conventional transmission electron microscopes, which require additional detectors, scanning coils, and circuitry, and dedicated STEMs, which have all the circuitry embedded. Low-voltage electron microscopes (LVEMs) combine the features of transmission electron microscopes, scanning electron microscopes, and STEMs. Operating at a low voltage, LVEMs provide high contrast images, which is essential for studying biological specimens. LVEMs are available in benchtop mode and are one of the smallest multimode desktop electron microscopes. Cryo-EM uses frozen samples, gentle electron beams, and sophisticated image processing to study biomolecules without the need for crystals. Cryo-EM allows scientists to observe biomolecules as they perform their functions, making it an invaluable tool in the field of biology. Liquid-phase TEM (LP-TEM) ensures in-situ observations of materials in liquids at the highest spatial and temporal resolution in controlled environments. LP-TEM is crucial for studying fluid properties and temperature, but caution must be taken for changes induced by electron beams in pH, nucleation rate, and radiolysis. Overall, the advancements in transmission electron microscopes are driving the growth of the global transmission electron microscope market. These new forms of microscopes offer unique benefits, making them indispensable tools in various industries, including materials science, biology, and electronics. 

The Transmission Electron Microscope (TEM) market is experiencing significant growth due to its application in various industries. In life sciences, TEMs are crucial for cancer research and virology, providing 2D images of specimens at the nanoscale. In materials sciences, TEMs help analyze semiconductors and wafers, enabling the study of their 3D structure and properties. TEMs are also essential in pollution research, nanotechnology, paleontology, and palynology. Industries like automotive, aerospace, electronics, oil & gas, environmental, water treatment, hospitals, diagnostic centers, blood banks, and forensic labs rely on TEMs for their research and development. TEMs offer high throughput methods, super resolution, digitization, live-cell imaging, and expansion and multi-view microscopes. Sample preparation techniques have also advanced, making TEMs more accessible. Neutron spectroscopy, X-ray diffraction, and electron microscopy imaging are complementary techniques that enhance TEM’s capabilities. TEMs operate at the de Broglie wavelength, enabling the study of nanometers-scale objects. Overall, the TEM market is expanding, driven by its applications in various industries and advancements in technology. 

Insights on how AI is driving innovation, efficiency, and market growth- Request Sample!

Market Challenges

The Transmission Electron Microscope (TEM) market faces significant challenges due to the high initial investment cost and the dependence on government and corporate funding for research institutes. This funding can be unpredictable, leading to market volatility. Additionally, high import duties and taxes, such as customs duties, imposed by various governments can increase the final product cost. Some countries, like the US, China, Canada, India, and Brazil, levy indirect taxes at both the national and state levels, with tax rates ranging from 11% to 17%. These taxes and excise duties contribute to the overall increase in product costs, potentially hindering the growth of the global TEM market during the forecast period.The Transmission Electron Microscope (TEM) market faces several challenges in various industries. In research centers, the use of licensed closed-source software limits the flexibility and collaboration among researchers. In electronics and medicine, the need for advanced microscopes for nanotechnology, surface physics, and surface analyses is growing, requiring significant investment. For solid specimens, TEMs offer unparalleled magnification, making them essential for gemology, medical sciences, forensic sciences, and more. However, the complex electron gun, condenser system, objective lens, movable specimen stage, image-recording system, and vacuum system make TEM instruments expensive and challenging to operate. The market for TEMs is expanding in nanomaterials, energy-related materials, polymers, glassy substances, biomolecular mechanisms, viruses, macromolecular complexes, and cellular structures. Industries, including catalysis research, environmental particles, and the nanoworld, rely on TEMs for scientific research and technological innovation. The electron source and electron optics system in a vacuum environment enable the study of ultrafast processes, making TEMs indispensable tools. Environmental TEMs and beam chopper technology, such as UTEM, offer solutions for specific applications. Overall, the TEM market’s growth is driven by the need for deeper understanding and discovery in various fields.

Insights into how AI is reshaping industries and driving growth- Download a Sample Report

Segment Overview 

This transmission electron microscope market report extensively covers market segmentation by

Application 1.1 Life science1.2 Material science1.3 Nanotechnology1.4 Semiconductor1.5 OthersEnd-user 2.1 Industries2.2 Academic institutes2.3 OthersGeography 3.1 APAC3.2 North America3.3 Europe3.4 South America3.5 Middle East and AfricaCountry
China, US, Japan, South Korea, and Canada

1.1 Life science-  Transmission Electron Microscopes (TEMs) play a crucial role in the field of life sciences, particularly in microbiology, by enabling researchers to examine microorganisms and their structures at the atomic level. These advanced instruments allow scholars to study intricate details of cellular environments, contributing significantly to the understanding of cell behavior, structure, and growth. With the potential to develop new drugs and medicines, academic institutions and pharmaceutical firms invest heavily in TEM technology. For instance, the Pennsylvania State University’s acquisition of FEI Company’s Titan/Krios TEM, which operates at extremely low temperatures, enhances their research capabilities and opens new avenues for exploration. TEMs enable the creation of 3D images of biological molecules such as DNA, proteins, and viruses, including the SARS-CoV-2 virus causing COVID-19. This technology’s ability to produce high-resolution images of these structures aids in the development of new vaccines and treatments. The ongoing research on single-dose COVID-19 vaccines is expected to fuel the demand for TEMs in the global market during the forecast period.

Download complimentary Sample Report to gain insights into AI’s impact on market dynamics, emerging trends, and future opportunities- including forecast (2024-2028) and historic data (2017 – 2021) 

Research Analysis

The Transmission Electron Microscope (TEM) market encompasses a wide range of industries and applications, driven by the need for high-resolution imaging and analysis of nanoscale objects. TEM utilizes the principle of de Broglie wavelength, allowing electrons to pass through thin samples and create detailed images. Applications span various fields such as cancer research, virology, materials sciences, nanotechnology, paleontology, and palynology. Industries like life sciences, automotive, aerospace, electronics, oil & gas, environmental, water treatment, and research institutes, hospitals, diagnostic centers, blood banks, and forensic labs all benefit from TEM technology. Semiconductors and X-ray diffraction are also significant applications. TEMs, including Scanning Transmission Electron Microscopes (STEMs), are essential tools for studying nanometers-scale structures, providing valuable insights into their properties and behavior.

Market Research Overview

Transmission Electron Microscopes (TEMs) use the principle of de Broglie wavelength to generate high-resolution 2D images of specimens at the nanoscale. TEMs differ from light microscopes as they employ an electron gun and condenser system instead of light to illuminate the specimen. TEMs have significant applications in various fields such as cancer research, virology, materials sciences, pollution analysis, nanotechnology, paleontology, and palynology. They provide detailed information on the 3D structure of nanoscale objects, semiconductors, wafers, and other materials. TEMs are used extensively in the life sciences, semiconductor industry, automotive, aerospace, electronics, oil & gas, environmental, water treatment, hospitals, diagnostic centers, blood banks, forensic labs, and other industries. TEMs offer advanced features like live-cell imaging, super resolution, high throughput methods, expansion microscopes, multi-view microscopes, and integrated microscopy workflows. Sample preparation is crucial for obtaining high-quality images, and TEMs require specialized equipment and expertise. TEMs use closed-source and proprietary software, which can be expensive, while open-source software like ImageJ/Fiji, Neuronstudio, and L-measure offer cost-effective alternatives for small-scale end users. TEMs require skilled operators, including physicists, laboratory technicians, and other experts. The electron gun and objective lens focus the electron beam on the specimen, while the condenser system controls the illumination. The electron beam interacts with the specimen, producing various signals that are used to form the image. Neutron spectroscopy, X-ray diffraction, and electron microscopy imaging are complementary techniques used in conjunction with TEMs for comprehensive material analysis.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

ApplicationLife ScienceMaterial ScienceNanotechnologySemiconductorOthersEnd-userIndustriesAcademic InstitutesOthersGeographyAPACNorth AmericaEuropeSouth AmericaMiddle East And Africa

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/transmission-electron-microscope-market-to-grow-by-usd-528-8-million-2024-2028-driven-by-focus-on-nanotechnology-with-a-report-on-how-ai-is-reshaping-the-landscape—technavio-302351400.html

SOURCE Technavio

Continue Reading

Technology

World Wisdom Agriculture Technology Exploration, 2025 March focus on the World Irrigation Science and Technology Exhibition

Published

on

By

BEIJING, Jan. 16, 2025 /PRNewswire/ — From March 31 to April 2, 2025, the 11th Beijing International Wisdom Agriculture and Irrigation Technology Expo and World Irrigation Technology Conference will be held in Beijing National Convention Center. At the same time, the third Beijing International Water Conservancy Science and Technology Expo will be held.

The conference is an innovation highland linking digital agriculture and irrigation technology at home and abroad, and is also the most professional and largest wisdom agriculture and irrigation exhibition in China. With an exhibition area of 30,000 square meters, 800 enterprises from 33 countries and regions around the world will display the world’s leading advanced equipment and technology, including 20 of the world’s top 500 enterprises and listed companies.

15,000 buyers from more than 10 countries and regions such as the United States, Italy, the Netherlands, Israel, Australia, Spain, France, Turkey, Cyprus, Japan and South Korea will visit and purchase.

In the same period, the Southeast Asia Agricultural Irrigation System Promotion Conference, the Silk Road-countries and Russia Agricultural Irrigation System Promotion Conference, the Beijing International Wisdom Agriculture Conference, the world’s first new technology and new products promotion conference, the global intelligent agricultural equipment innovation Ceremony and other activities will be held, bringing together the world’s agricultural cutting-edge technology and promote international trade cooperation.

If you want to know about this exhibition,welcome to visit our website: www.chinaite.com.cn

CONTACT: Taoran Hu, 463611470@qq.com

View original content:https://www.prnewswire.com/apac/news-releases/world-wisdom-agriculture-technology-exploration-2025-march-focus-on-the-world-irrigation-science-and-technology-exhibition-302352835.html

SOURCE The 11th China(Beijing) International Irrigation Technology Exhibition

Continue Reading

Trending